cdk4 glutathione MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation Targeting CDK4/6 for Anticancer Therapy
Targeting CDK4 6 for Anticancer Therapy CDK4 and CDK6 kinases: From basic science to cancer therapy Science Inhibition of METTL14 overcomes CDK4 6 inhibitor resistance driven by METTL14 m6A E2F1 axis in ER positive breast cancer Journal of Nanobiotechnology Springer Nature Link Discovery of the GSH responsive Y PROTACs targeting ALK and CDK4 6 as a potential treatment for cancer ScienceDirect CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis Competent Conformations, Offering Drug Targets JACS Au Cyclin D CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation Circulation Research
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





